Retrospective findings of the clinical benefits of podophyllum resin 25% sol on hairy leukoplakia. Clinical results in nine patients.

@article{LozadaNur1992RetrospectiveFO,
  title={Retrospective findings of the clinical benefits of podophyllum resin 25% sol on hairy leukoplakia. Clinical results in nine patients.},
  author={Francina I Lozada-Nur and Carlos Eduardo F{\'a}vero Costa},
  journal={Oral surgery, oral medicine, and oral pathology},
  year={1992},
  volume={73 5},
  pages={555-8}
}
Hairy leukoplakia was first described as an oral marker of human immunodeficiency virus infection in 1984. The clinical significance of this lesion in an otherwise healthy, high-risk symptom-free person is that it can be an early manifestation of human immunodeficiency virus infection. Because of its benign nature and the lack of clinical evidence that treatment of the lesion improves the prognosis of human immunodeficiency virus-infected patients, systemic therapy with antiviral drugs does not… CONTINUE READING